Noninvasive tests detect advanced liver scarring and could reduce reliance on biopsies
Two major international studies have delivered the strongest evidence to date on which noninvasive tests can accurately diagnose and measure the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form, MASH, reducing reliance on liver biopsy.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
The parts of fruits and vegetables most throw away could save your health—and the planet
United Kingdom
-
Worried nuts will cause weight gain? A large review puts that concern in perspective
United Kingdom
-
Long-term follow-up tracks benefits and risks of stem cell transplants for severe systemic sclerosis
United Kingdom
-
Can broccoli sprouts help with insulin resistance? New review offers clues
United Kingdom
-
Could a few bad dietary choices worsen your next immune response?
United Kingdom
-
Fish, shellfish or seaweed? A Korean study found striking differences in chemical exposure
United Kingdom
-
How common dietary fats can aggravate chronic itch
United Kingdom
-
How psychedelics could deliver antidepressant benefits without hallucinogenic effects
United Kingdom